In its report on flu sample cross-contamination today, the CDC detailed departures from best practices and reporting delays.
Two leading experts urge both sides in the debate to keep an open mind and to set up a conference.
Journal editors call for specific steps, while the ASM said it wants the NAS to weigh the risks and benefits.
In its ongoing response to safety lapses at two of its high-containment labs, the US Centers for Disease Control and Prevention (CDC) today announced the members of an external lab safety work group. The 11-person group will advise CDC Director Tom Frieden, MD, MPH, and the CDC's new director of lab safety, Michael Bell, MD, according to a statement.
Officials from the US Centers for Disease Control and Prevention (CDC) said yesterday that it might be impossible to trace how H9N2 avian flu samples it sent to a US Department of Agriculture (USDA) lab in Athens, Ga., became cross-contaminated with the lethal H5N1 strain, Reuters reported yesterday.
The hearing revealed systemic problems and worries about the safety culture of lab workers.
The NSABB chair says delays in developing a DURC policy have been to blame.
Almost half of the board's voting members learned they will soon be replaced.
Their consensus statement calls for better tools to weigh risks and benefits.
A US House of Representatives committee that will host a hearing on Jul 16 to question federal officials on recent incidents involving anthrax bacteria and other pathogens at US Centers for Disease Control and Prevention (CDC) labs today unveiled some findings from its requests for documents and testimony about the agency's biosafety issues.
